Medicare Enrolled

Dr. Nithi Anand, MD

Neurology · Marietta, GA
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Speaking/Promotional
780 CANTON RD NE, Marietta, GA 30060
7704223602
In practice since 2006 (20 years)
NPI: 1346287760 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Anand from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Anand? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Anand

Dr. Nithi Anand is a neurology specialist in Marietta, GA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Anand performed 18,814 Medicare services across 691 unique beneficiaries.

Between the years covered by Open Payments, Dr. Anand received a total of $75,149 from 73 pharmaceutical and/or device companies across 759 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Anand is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 4% volume in GA $75,149 industry payments

Medicare Practice Summary

Medicare Utilization ↗
18,814
Medicare services
Top 4% in GA for neurology
691
Unique beneficiaries
$8
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~941 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Botox injection, per unit
An injection of onabotulinumtoxinA, a medication used to temporarily relax muscles or reduce gland activity. The dose is measured in units, with this code representing a single unit administered.
18,000 $5 $12
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
236 $89 $281
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
184 $55 $198
Bilateral facial and neck nerve muscle paralysis injection
Injection of a chemical agent to paralyze muscles in the face and neck on both sides.
92 $124 $404
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
79 $114 $375
Awake and drowsy EEG
A test that records electrical activity in the brain while the patient is awake and drowsy.
71 $42 $142
VEEG monitoring, 12-26 hours with review
This procedure involves monitoring brain wave activity along with video recording for 12 to 26 hours. A healthcare professional reviews the data and provides a report.
54 $164 $500
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
34 $81 $249
EEG brain wave monitoring, 41-60 minutes
This procedure involves monitoring and recording electrical activity in the brain using electrodes placed on the scalp for a duration of 41 to 60 minutes.
25 $41 $142
Electromyography of arm or leg muscles
A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them.
22 $75 $244
Video EEG monitoring, 2-12 hours
This procedure records brain wave activity while simultaneously capturing video footage for a duration of 2 to 12 hours. A healthcare professional reviews the data and provides a report.
17 $106 $281
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$75,149
Total received (2018-2024)
Avg $10,736/year across 7 years
Top 7% in GA for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
73
Companies
759
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$64,865 (86.3%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,907 (11.9%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$1,376 (1.8%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,381
2023
$7,405
2022
$9,260
2021
$17,302
2020
$24,541
2019
$12,451
2018
$2,808

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$405
Celgene Corporation
$185
PFIZER INC.
$145
UCB, Inc.
$135
ACADIA Pharmaceuticals Inc
$70
Amgen Inc.
$68
Otsuka America Pharmaceutical, Inc.
$58
Teva Pharmaceuticals USA, Inc.
$58
Sumitomo Pharma America, Inc.
$52
Lilly USA, LLC
$33
GE HEALTHCARE
$33
Averitas Pharma Inc.
$28
Eisai Inc.
$19
Octapharma USA, Inc.
$17
Novartis Pharmaceuticals Corporation
$16
SCILEX PHARMACEUTICALS INC.
$16
Acorda Therapeutics, Inc
$16
Alexion Pharmaceuticals, Inc.
$15
Biogen, Inc.
$13
Top 3 companies account for 53.1% of 2024 payments
All-time payments by company (2018-2024) ›
Amgen Inc.
$24,854
Allergan, Inc.
$19,664
AbbVie Inc.
$12,305
ABBVIE INC.
$4,213
Lilly USA, LLC
$2,439
Biohaven Pharmaceutical Holding Company Ltd.
$1,746
Lundbeck LLC
$1,464
Teva Pharmaceuticals USA, Inc.
$574
Novartis Pharmaceuticals Corporation
$533
UCB, Inc.
$521
Supernus Pharmaceuticals, Inc.
$491
ACADIA Pharmaceuticals Inc
$483
Biogen, Inc.
$424
EMD Serono, Inc.
$407
Celgene Corporation
$363
Alexion Pharmaceuticals, Inc.
$335
Sunovion Pharmaceuticals Inc.
$302
CSL Behring
$267
Allergan Inc.
$261
GENZYME CORPORATION
$256
PFIZER INC.
$228
GE HEALTHCARE
$196
GE Healthcare
$189
Acorda Therapeutics, Inc
$186
Otsuka America Pharmaceutical, Inc.
$130
Grifols USA, LLC
$129
Harmony Biosciences LLC
$121
JAZZ PHARMACEUTICALS INC.
$120
Promius Pharma LLC
$115
Biohaven Pharmaceuticals, Inc.
$104
Upsher-Smith Laboratories LLC
$99
Sumitomo Pharma America, Inc.
$97
UPSHER-SMITH LABORATORIES LLC
$84
Bausch Health US, LLC
$80
Avanir Pharmaceuticals, Inc.
$76
Neurocrine Biosciences, Inc.
$74
EISAI INC.
$67
Horizon Therapeutics plc
$63
Amneal Pharmaceuticals LLC
$58
E.R. Squibb & Sons, L.L.C.
$57
AbbVie, Inc.
$56
W. L. Gore & Associates, Inc.
$55
US WorldMeds, LLC
$54
Octapharma USA, Inc.
$51
Eisai Inc.
$45
Janssen Pharmaceuticals, Inc
$42
ARGENX US, INC.
$39
Genentech USA, Inc.
$37
Mallinckrodt Enterprises LLC
$35
Mallinckrodt LLC
$33
Mylan Pharmaceuticals Inc.
$32
Avion Pharmaceuticals
$32
ASSERTIO THERAPEUTICS, Inc.
$29
Egalet US Inc
$28
Averitas Pharma Inc.
$28
Impax Laboratories, Inc.
$28
Bayer HealthCare Pharmaceuticals Inc.
$26
GE HealthCare
$26
Arbor Pharmaceuticals, Inc.
$26
Greenwich Biosciences, Inc.
$25
IMPEL PHARMACEUTICALS INC.
$24
SANOFI-AVENTIS U.S. LLC
$24
Medtronic USA, Inc.
$24
BANNER LIFE SCIENCES, LLC
$23
TG THERAPEUTICS, INC.
$22
Takeda Pharmaceuticals U.S.A., Inc.
$22
Azurity Pharmaceuticals, Inc.
$18
Ipsen Biopharmaceuticals, Inc
$17
SCILEX PHARMACEUTICALS INC.
$16
Assertio Therapeutics, Inc.
$16
Abbott Laboratories
$16
Mitsubishi Tanabe Pharma America, Inc.
$15
Aprecia Pharmaceuticals, LLC
$12
Top 3 companies account for 75.6% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AFINITOR · AIMOVIG · AJOVY · AMPYRA · AMYVID · APOKYN · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Aimovig · Austedo XR · BAFIERTAM · BOTOX · BOTOX THERAPEUTIC · BRIUMVI · Betaseron · Briviact · COPAXONE · Cambia · DUOPA · Dhivy · Duopa · Dysport · ELYXYB - CELECOXIB · EMGALITY · EPIDIOLEX · Epidiolex · Fintepla · Fycompa · GILENYA · GORE CARDIOFORM Septal Occluder · Gamunex-C · Glatiramer Acetate · Gralise · Hizentra · Horizant · INBRIJA · INGREZZA · Infinity DBS Pulse Generators · KESIMPTA · KISUNLA · KYNMOBI · LEMTRADA · LUMIZYME · LYRICA · Leqembi · MAVENCLAD · MAYZENT · MIGRANAL · Mavenclad · NAMZARIC · NORTHERA · NUEDEXTA · NUPLAZID · NURTEC ODT · Neupro · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONFI · Ongentys · PANZYGA · PAXLOVID · POMPE - DISEASE · Ponvory · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · QUTENZA · RESTORE · REXULTI · RYTARY · Radicava · Rebif · SOLIRIS · SPINRAZA · SPRIX · Soliris · Solitaire · Spritam · TECFIDERA · TOSYMRA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TROKENDI XR · TYSABRI · Trintellix · Trudhesa · UBRELVY · ULTOMIRIS · UPLIZNA · VRAYLAR · VYEPTI · VYVGART · WAKIX · Wakix · XYREM · XYWAV · Xadago · ZEMBRACE SYMTOUCH · ZEPOSIA · Zembrace · Zilbrysq
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (86%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in neurology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 7% for neurology in GA.

Looking for a neurology specialist in Marietta?
Compare neurologists in the Marietta area by procedure volume, costs, and industry payment transparency.
Browse neurologists nearby

Geographic Context

Neurologists within 10 mi
219
Per 100K population
28.5
County median income
$98,712
Nearest hospital
WELLSTAR KENNESTONE REGIONAL MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Anand is a mixed practice specialist, with above-average Medicare volume (top 4% in GA), with speaking/promotional industry engagement in the top 7% of GA peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Anand experienced with botox injection, per unit?
Based on Medicare claims data, Dr. Anand performed 18,000 botox injection, per unit services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Anand receive payments from pharmaceutical companies?
Yes. Dr. Anand received a total of $75,149 from 73 companies across 759 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Anand's costs compare to other neurologists in Marietta?
Dr. Anand's average Medicare payment per service is $8. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Anand) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →